Remarks by: Linda Suydam, D.P.A. Senior Associate Commissioner Food and Drug Administration for ISPE Annual Meeting, New Orleans, LA November 1, 1999 Good morning. I am pleased and honored to be here, and to bring you the greetings of FDA Commissioner, Dr. Henney. And also, her thanks. Dr. Henney asked me to express her appreciation for all the work you have done in collaboration with our agency such as your help with the baseline guides, the SUPAC equipment addenda, and the planning for SUPAC training workshops. The Commissioner is also very pleased that your members around the world emphasize the importance of good manufacturing practices and high engineering and product standards for the production of safe and effective drugs and devices. At FDA, we are reminded almost daily that in today's world of highly mobile people and goods, effective public health protection must begin far beyond our borders. And of course, our workload never lets us forget that the job of managing public health risks, which is the core of our mission, cannot be done by FDA alone that, as a task force reported to Dr. Henney earlier this year, all of us in the health-care community must contribute to that cause. So it is truly gratifying to have such a partner as ISPE, an organization that understands this need, that cares, and whose work throughout the globe contributes to the quality of public health protection in the United States. | |
|
